Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Paukenschlag in USA: Cannabis-Neuregulierung durch DEA sorgt für Kursexplosion!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
19 Leser
Artikel bewerten:
(0)

Neurosurgery Market Growing at 11.7% CAGR to 2019, Globally, Forecasts a New Neurosurgery Industry Research Report

DALLAS, January 17, 2015 /PRNewswire/ --

ReportsnReports.com adds Global Neurosurgery Market 2015-2019 research report of 75 pages, which says that an increase in the number of diagnosed neurological disorders has resulted in the growth of global neurosurgery market.

One major trend upcoming in the neurosurgery market is the increased adoption of neurostimulators to treat migraines, chronic pain, epilepsy, post-cancer therapy pain, lower back pain, and Parkinson's disease. Clinical evidence supporting the use of neurostimulation devices is increasing their adoption rate among neurosurgeons. Approximately 12% of deaths worldwide are caused by neurological disorders like epilepsy, Alzheimer's and Parkinson's. Cost-effectiveness and the cost-to-utility ratio of neurostimulation devices are slightly higher as compared to drugs, which are used as symptomatic treatment options over long durations. The use of neurostimulation devices for the treatment of neurological disorders, particularly among the elderly, is expected to bolster the growth of the market.

Additionally, the neurosurgery market has also witnessed an increase in the use of frameless stereotaxic. Frameless stereotactic feedback enables doctors to perform surgery using a smaller incision and also reduces the risk of inadvertent venous sinus injury. Neurosurgery is a complex surgical procedure that involves diagnosis, treatment, and rehabilitation of disorders affecting any region of the nervous system. Some of the common neurosurgeries are endovascular neurosurgery, stereotactic neurosurgery, oncological neurosurgery, craniotomy, and neuroendoscopy. These surgeries are performed to treat neurological disorders, tumors, trauma, and injuries. The devices used to perform neurosurgeries are neurosurgical devices.

Analysts forecast the Global Neurosurgery market to grow at a CAGR of 11.71% over the period 2014-2019. According to the report, a major factor driving this market is the increase in the prevalence of neurological disorders. These disorders include Alzheimer's disease, Parkinson's disease, stroke, migraine, depression, angina, obsessive-compulsive disorder, multiple sclerosis, neurological infections, and brain tumors.

Further, the report states that the high cost of the equipment required for neurosurgery hinders its adoption by hospitals and other healthcare facilities. High installation costs and lack of reimbursement from insurance companies add to the upfront capital expenditure of hospitals.

The Global Neurosurgery market is divided into five segments based on product type, namely, Neurostimulation Services, Neuro-interventional Devices, CSF Management Devices, Neurosurgical Navigation Systems and Others (neuroendoscopes, ultrasonic aspirators, stereotactic systems, and aneurysm clips).

The Global Neurosurgery Market 2015-2019 report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Neurosurgery market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The report talks about key players in the Global Neurosurgery Market like Codman & Shurtleff Inc., Integra LifeSciences Corp., Medtronic Inc. and Stryker Corp. Other Prominent Vendors in the market are Afferent, B. Braun Melsungen, Boston Scientific, BrainLab, Cyberkinetics Neurotechnology Systems, Cyberonics, Elekta, Karl Storz, Micromar, Neuros Medical, NeuroVista, Scopis, SPR Therapeutics, St. Jude Medical and Synapse Biomedical. Order a copy of this report at (Prices start at US $ 2500 for a single user PDF) http://www.reportsnreports.com/Purchase.aspx?name=323156 .

The Surgical Imaging Market by Product (Mobile C-arm/ Mini C-arm) & by Application (Orthopedic and Trauma/Neurosurgery/Cardiovascular/Hand and Wrist/ Foot and Ankle/ Pediatric) - Competitive Landscape, Global Forecasts & Trends to 2019 research report says global surgical imaging market was valued at an estimated $933.6 million in 2014 and is expected to grow at a CAGR of 6.0% from 2014 to 2019. North America accounted for the largest share of the global surgical imaging market followed by Europe and Asia valued at $378.6 million in 2014.The dominance of the North American market can be attributed to reasons such as the increasing prevalence of sports injuries in this region as well as the availability of private and government funding for the purchase of surgical imaging equipment.

The European region is expected to grow at a steady pace as well. The leading players in the surgical imaging market are headquartered in Europe. Furthermore, they have a well-established internal and external distribution channels. Also, Europe hosts an array of mid-sized surgical imaging equipment manufacturers such as Eurocolumbus SRL (Italy) and Cat Medical Systems S.P.A (Italy). Furthermore, the rise in aging population, increase in the adoption of surgical imaging equipment by the hospitals, and established medical tourism for minimally invasive surgeries are some of the factors driving growth in the region. However, the Asian market slated at an estimated CAGR of 8.3%, will experience the highest growth in the surgical imaging market. The high growth in the Asian region can be attributed to increase in aging population, rise in the number of hospitals, government funding, and the availability of competitively priced surgical imaging equipment.

GE Healthcare (U.K.), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Ziehm Imaging (Germany), Toshiba Corporation (Japan), Shimadzu Corporation (Japan), Hologic, Inc. (U.S.), OrthoScan (U.S.) and Eurocolumbus (Italy) are some of the prominent players in the global surgical imaging market. Complete report is available at http://www.reportsnreports.com/reports/312735-surgical-imaging-market-by-product-mobile-c-arm-mini-c-arm-by-application-orthopedic-and-trauma-neurosurgery-cardiovascular-hand-and-wrist-foot-and-ankle-pediatric-competitive-landscape-global-forecasts-trends-to-2019.html .

Explore more reports on pharmaceuticals as well as other newly published research on the medical devices market at http://www.reportsnreports.com/market-research/medical-devices/ .

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers on a range of categories and industries.

Contact:

Ritesh Tiwari / Priyank Tiwari

TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252

Tel: +1-888-391-5441

sales@reportsandreports.com

Connect with Us:

G+ / Google Plus:https://plus.google.com/u/0/111656568937629536321/posts

Twitter:http://twitter.com/marketsreports

Facebook:https://www.facebook.com/pages/ReportsnReports/191441427571689

RSS / Feeds:http://www.reportsnreports.com/feed/l-latestreports.xml


Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.